OrbiMed’s Chemomab Therapeutics CMMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Sell |
235,248
-200,070
| -46% | -$928K | 0.03% | 89 |
|
|
2025
Q1 | $1.9M | Hold |
435,318
| – | – | 0.05% | 89 |
|
|
2024
Q4 | $3.15M | Hold |
435,318
| – | – | 0.06% | 90 |
|
|
2024
Q3 | $2.73M | Sell |
435,318
-125,000
| -22% | -$785K | 0.05% | 100 |
|
|
2024
Q2 | $2.05M | Sell |
560,318
-1
| -0% | -$4 | 0.04% | 98 |
|
|
2024
Q1 | $1.75M | Hold |
560,319
| – | – | 0.03% | 103 |
|
|
2023
Q4 | $1.14M | Hold |
560,319
| – | – | 0.02% | 102 |
|
|
2023
Q3 | $2.01M | Hold |
560,319
| – | – | 0.04% | 106 |
|
|
2023
Q2 | $2.95M | Hold |
560,319
| – | – | 0.05% | 106 |
|
|
2023
Q1 | $3.56M | Sell |
560,319
-84,225
| -13% | -$536K | 0.07% | 104 |
|
|
2022
Q4 | $8.25M | Hold |
644,544
| – | – | 0.16% | 78 |
|
|
2022
Q3 | $6.42K | Hold |
644,544
| – | – | 0.12% | 99 |
|
|
2022
Q2 | $9.54K | Hold |
644,544
| – | – | 0.17% | 91 |
|
|
2022
Q1 | $12.4M | Hold |
644,544
| – | – | 0.2% | 92 |
|
|
2021
Q4 | $17.8M | Hold |
644,544
| – | – | 0.23% | 89 |
|
|
2021
Q3 | $28.6M | Hold |
644,544
| – | – | 0.31% | 80 |
|
|
2021
Q2 | $49M | Hold |
644,544
| – | – | 0.5% | 57 |
|
|
2021
Q1 | $74M | Buy |
+644,544
| New | +$74M | 0.69% | 43 |
|